Sastasundar Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the Unaudited Standalone ....
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures Limited has informed BSE that a meeting of its Board of Directors is scheduled for Thursday, 13 November 2025. The Board will inter-alia consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September 2025. The filing is made under Regulation 29 of SEBI's LODR Regulations, 2015. The trading window for dealing in the company's securities remains closed until 48 hours after the results are declared to the stock exchanges.
This is a routine pre-results intimation with no immediate impact on the stock. Investors should track the actual Q2/H1 FY26 results announcement on 13 November 2025, which could trigger a price move based on the reported numbers.